EP1527084A4
Promoters exhibiting endothelial cell specificity and methods of using same
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 30 April 2023, 3.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
42 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39 Sheet 40 Sheet 41 Sheet 42
Every citation, both waysCites: the store holds 4 of 5
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO0006759A2 | Cites | World Intellectual Property Organization (WIPO) | X | Search report | 1-44 |
| WO0240629A2 | Cites | World Intellectual Property Organization (WIPO) | PX | Search report | 1-44 |
| WO0240629A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| WO0006759A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| BU XIN ET AL: "Identification of an endothelial cell-specific regulatory region in the murine endothelin-1 gene", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 51, 19 December 1997 (1997-12-19), pages 32613 - 32622, XP002349278, ISSN: 0021-9258 | Non-patent | – | – | Search report | – |
| VARDA-BLOOM N ET AL: "Tissue-specific gene therapy directed to tumor angiogenesis", GENE THERAPY, vol. 8, no. 11, June 2001 (2001-06-01), pages 819 - 827, XP002349279, ISSN: 0969-7128 | Non-patent | – | – | Search report | – |
| HARATS DROR ET AL: "Targeting Gene Expression to the Vascular Wall in Transgenic Mice Using the Murine Preproendothelin-1 Promoter", JOURNAL OF CLINICAL INVESTIGATION, vol. 95, no. 3, 1995, pages 1335 - 1344, XP002349280, ISSN: 0021-9738 | Non-patent | – | – | Search report | – |
| MINCHENKO ALEXANDER ET AL: "Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: Role of hypoxia responsive element", MOLECULAR AND CELLULAR BIOCHEMISTRY, NORWELL, MA, US, vol. 208, no. 1-2, May 2000 (2000-05-01), pages 53 - 62, XP002305520, ISSN: 0300-8177 | Non-patent | – | – | Search report | – |
| GREENBERGER SHOSHANA ET AL: "Transcription-control led gene therapy against tumor angiogenesis", JOURNAL OF CLINICAL INVESTIGATION, vol. 113, no. 7, April 2004 (2004-04-01), pages 1017 - 1024, XP002349281, ISSN: 0021-9738 | Non-patent | – | – | Search report | – |
184 members in 20 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 135447 | United States of America | – | |
| 13544702 | United States of America | A | |
| 13544702 | United States of America | A | |
| 0300347 | Israel | W | |
| 0300347 | Israel | W | |
| 135447 | – | – | – |
| IL2003000347 | – | – | – |
| US20020135447 | – | – | – |
| WO2003IL00347 | – | – | – |
Members184
| Document | Office | Kind | |
|---|---|---|---|
| CA2429342A1 | Canada | A1 | |
| WO0240629A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2400202A | Australia | A | |
| CA2463816A1 | Canada | A1 | |
| WO03033514A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2003124100A1 | United States of America | A1 | |
| CA2483996A1 | Canada | A1 | |
| WO03093409A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003222427A1 | Australia | A1 | |
| AU2003222427A2 | Australia | A2 | |
| IL155940A0 | Israel | A0 | |
| MXPA03004325A | Mexico | A | |
| US2004048280A1 | United States of America | A1 | |
| KR20040048370A | Republic of Korea | A | |
| WO0240629A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1436313A1 | European Patent Office (EPO) | A1 | |
| MXPA04003514A | Mexico | A | |
| EP1443970A2 | European Patent Office (EPO) | A2 | |
| US2004197860A1 | United States of America | A1 | |
| KR20040094391A | Republic of Korea | A | |
| JP2004534509A | Japan | A | |
| KR20040104685A | Republic of Korea | A | |
| EP1443970A4 | European Patent Office (EPO) | A4 | |
| MXPA04010711A | Mexico | A | |
| CN1592638A | China | A | |
| WO03093409A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CN1602315A | China | A | |
| HK1067641A | Hong Kong, China | A | |
| HK1067641A1 | Hong Kong, China | A1 | |
| HK1068057A | Hong Kong, China | A | |
| HK1068057A1 | Hong Kong, China | A1 | |
| EP1527084A2 | European Patent Office (EPO) | A2 | |
| US2005112110A1 | United States of America | A1 | |
| JP2005523718A | Japan | A | |
| US2005186179A1 | United States of America | A1 | |
| JP2005532031A | Japan | A | |
| CN1703420A | China | A | |
| EP1527084A4This record | European Patent Office (EPO) | A4 | |
| EP1436313A4 | European Patent Office (EPO) | A4 | |
| AU2005303385A1 | Australia | A1 | |
| CA2587469A1 | Canada | A1 | |
| CA2913047A1 | Canada | A1 | |
| WO2006051545A2 | World Intellectual Property Organization (WIPO) | A2 | |
| ZA200402756B | South Africa | B | |
| US7067649B2 | United States of America | B2 | |
| NZ532348A | New Zealand | A | |
| ZA200408989B | South Africa | B | |
| US2006204478A1 | United States of America | A1 | |
| WO2006051545A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2002307793B2 | Australia | B2 | |
| AU2002224002B2 | Australia | B2 | |
| EP1814897A2 | European Patent Office (EPO) | A2 | |
| IL183187A0 | Israel | A0 | |
| KR20070086209A | Republic of Korea | A | |
| AU2007219088A1 | Australia | A1 | |
| CA2638829A1 | Canada | A1 | |
| WO2007096882A2 | World Intellectual Property Organization (WIPO) | A2 | |
| MX2007005783A | Mexico | A | |
| EP1814897A4 | European Patent Office (EPO) | A4 | |
| US2007286845A1 | United States of America | A1 | |
| CN101098882A | China | A | |
| JP2008519596A | Japan | A | |
| KR20080083031A | Republic of Korea | A | |
| MX2008010859A | Mexico | A | |
| JP4173446B2 | Japan | B2 | |
| KR100866117B1 | Republic of Korea | B1 | |
| KR20080096843A | Republic of Korea | A | |
| AU2008243817A1 | Australia | A1 | |
| CA2685394A1 | Canada | A1 | |
| WO2008132729A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP1988926A2 | European Patent Office (EPO) | A2 | |
| KR100869814B1 | Republic of Korea | B1 | |
| US2008305088A1 | United States of America | A1 | |
| IL155940A | Israel | A | |
| ZA200704687B | South Africa | B | |
| CN100457190C | China | C | |
| WO2007096882A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP4243653B2 | Japan | B2 | |
| IL193554A0 | Israel | A0 | |
| CN101443049A | China | A | |
| CN100506284C | China | C | |
| US7579327B2 | United States of America | B2 | |
| US7585666B2 | United States of America | B2 | |
| KR100917854B1 | Republic of Korea | B1 | |
| WO2008132729A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CN101570764A | China | A | |
| NZ555612A | New Zealand | A | |
| US2009326052A1 | United States of America | A1 | |
| EP1443970B1 | European Patent Office (EPO) | B1 | |
| AT455562T | Austria | T | |
| ATE455562T1 | Austria | T1 | |
| KR20100017114A | Republic of Korea | A | |
| EP2152317A2 | European Patent Office (EPO) | A2 | |
| DE60141175D1 | Germany | D1 | |
| AU2003222427B2 | Australia | B2 | |
| US2010081193A1 | United States of America | A1 | |
| EP2174668A2 | European Patent Office (EPO) | A2 | |
| MX2009011750A | Mexico | A | |
| AU2003222427B8 | Australia | B8 | |
| ES2338529T3 | Spain | T3 |
Showing 100 of 184
10 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Applications withdrawn, deemed to be withdrawn, or refused after publication in hong kongWithdrawnWD | WD | HK | |
| Application deemed to be withdrawnWithdrawn18D | 18D | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1527084
- Publication, DOCDB
- 1527084
- Publication, EPODOC
- EP1527084
- Application
- 3717516
- Application, DOCDB
- 03717516
- Application, EPODOC
- EP20030717516
Titles3
- German
- ENDOTHELZELLENSPEZIFITÄT ZEIGENDE PROMOTOREN UND VERFAHREN ZUR VERWENDUNG DAVON
- English
- PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME
- French
- PROMOTEURS PRESENTANT UNE SPECIFICITE POUR LES CELLULES ENDOTHELIALES ET METHODES D'UTILISATION CORRESPONDANTE
Classification
- CPC, 18
- A61K48/0058
- C12N15/113
- A61K48/00
- C07K14/475
- C07K14/515
- C07K14/57536
- C12N15/85
- C12N2830/001
- C12N2830/002
- C12N2830/008
- C12N2830/15
- C12N2830/42
- C12N2830/85
- C12N2840/445
- A61P17/00
- A61P35/00
- A61P43/00
- A61P9/00
- IPC, 13
- A61K31 7088
- C12N15 09
- A61K45 06
- A61K48 00
- A61P9 00
- A61P17 00
- A61P35 00
- A61P43 00
- C07K14 475
- C07K14 515
- C07K14 575
- C12N5 10
- C12N15 85
Designated states2
- Contracting states, 1
- Türkiye
- Extension states, 1
- North Macedonia